Neurobiology of Opioid Dependence: 4 - 4
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000195 |
Recruitment Status :
Withdrawn
First Posted : September 21, 1999
Last Update Posted : May 6, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Opioid-Related Disorders | Drug: Naltrexone | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Intervention Model: | Crossover Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | Neurobiology of Opioid Dependence: 4 |
Study Start Date : | January 1993 |
Actual Primary Completion Date : | January 1998 |
Actual Study Completion Date : | January 1998 |

- Behavioral, physiological, neuroendocrine response to yohimine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000195
United States, Connecticut | |
VA Connecticut Healthcare System | |
New Haven, Connecticut, United States, 06519 |
Principal Investigator: | Marc I Rosen, M.D. | VA Connecticut Healthcare System |
Responsible Party: | Yale University |
ClinicalTrials.gov Identifier: | NCT00000195 |
Other Study ID Numbers: |
NIDA-00191-4 K20DA000191 ( U.S. NIH Grant/Contract ) K20-00191-4 |
First Posted: | September 21, 1999 Key Record Dates |
Last Update Posted: | May 6, 2016 |
Last Verified: | August 2015 |
opioid disorders |
Opioid-Related Disorders Narcotic-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders Naltrexone |
Alcohol Deterrents Narcotic Antagonists Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents |